TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD
31.75
-1.160 -3.654%
Share volume: 9,906,552
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$32.91
-1.16
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 07-31-2024 | 11-06-2024 | 02-05-2025 | 05-07-2025 | 07-30-2025 | 11-05-2025 | 02-03-2026 | |
| Total revenue | 3.819 B | 4.164 B | 4.332 B | 4.229 B | 3.891 B | 4.176 B | 4.480 B | 4.711 B | |
| Cost of revenue | 2.048 B | 2.140 B | 2.183 B | 2.110 B | 2.014 B | 2.074 B | 2.176 B | 2.056 B | |
| Gross profit | 1.771 B | 2.024 B | 2.148 B | 2.121 B | 1.877 B | 2.102 B | 2.304 B | 2.655 B | |
| 14.29% | 6.13% | -1.26% | -11.50% | 11.99% | 9.61% | 15.23% | |||
| Operating expenses | 1.128 B | 1.208 B | 538.000 M | 549.000 M | 544.000 M | 549.000 M | 573.000 M | 634.000 M | |
| Selling general and admin | 886.000 M | 939.000 M | 298.000 M | 302.000 M | 297.000 M | 305.000 M | 317.000 M | 368.000 M | |
| Research and development | 242.000 M | 269.000 M | 240.000 M | 247.000 M | 247.000 M | 244.000 M | 256.000 M | 266.000 M | |
| Total expenses | 3.176 B | 3.348 B | 2.198 B | 2.150 B | 1.356 B | 1.647 B | 1.422 B | 2.355 B | |
| 5.42% | -34.35% | -2.18% | -36.93% | 21.46% | -13.66% | 65.61% | |||
| Operating income | 643.000 M | 816.000 M | -51.000 M | -29.000 M | 519.000 M | 455.000 M | 882.000 M | 301.000 M | |
| Ebit | 639.000 M | 818.000 M | -323.000 M | -247.000 M | 294.000 M | 203.000 M | 645.000 M | 81.000 M | |
| Pretax income | -471.000 M | -245.000 M | -324.000 M | -247.000 M | 294.000 M | 203.000 M | 646.000 M | 80.000 M | |
| -47.98% | 32.24% | -23.77% | -219.03% | -30.95% | 218.23% | -87.62% | |||
| Income tax | -52.000 M | 630.000 M | 69.000 M | 29.000 M | 74.000 M | -78.000 M | 214.000 M | -390.000 M | |
| Net income basic | -139.000 M | -846.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -508.63% | 100.00% | ||||||||
| Net income | -139.000 M | -846.000 M | -390.000 M | -276.000 M | 220.000 M | 283.000 M | 434.000 M | 481.000 M | |
| -508.63% | 53.90% | 29.23% | 179.71% | 28.64% | 53.36% | 10.83% |